New - CAP - One Year Requirement
Veterans Affairs · 257-NETWORK CONTRACT OFFICE 17 (36C257)
Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.
Where this opportunity stands
Every notice posted under solicitation 36C25727Q0008 in this department, oldest first.
- Sep 9, 2026 · this noticeSpecial Notice
Next steps for this stage
Standard steps for the notice type; not advice about this buyer.
- Answer the notice: this is when the requirement can still be shaped.
- Contact the contracting officer named on the notice.
- Check who won similar work; they are the likely bidders.
What the notice says
Special Notice � Notice of Intent to Award a Sole Source Procurement The Department of Veterans Affairs, Veterans Health Administration, Network Contracting Office 17, intends to award a firm-fixed priced contract to The College of American Pathologists for procurement of the following requirement: Purpose All VHA Pathology and Laboratory Medicine Service (P&LMS) laboratories and Ancillary Testing Sites that perform patient testing, regardless of complexity, must subscribe to an external proficiency testing program that meets the Clinical Laboratory Improvement Act 1988 (CLIA �88) and its amen… (show all)
dments; to ensure reliability of patient testing and meet accreditation requirements. Many testing systems within P&LMS also require validation of the Analytical Measurement Range (AMR) for an analyte both initially and at least every six months thereafter. This can be accomplished through purchase of linearity material that is both matrix specific and spans the range of the AMR for each analyte, when required. This is addressed in 42 CFR 493.1255 (b) and the College of American Pathologists (CAP) standard CHM.13600. This Statement of Work (SOW) is requesting the procurement of proficiency and linearity materials that are not provided through the P&LMS VA Central Office (VACO); but are still required by the guidelines set forth in VA Handbook 1106, 42 CFR 493 Subpart H and K, and many CAP standards. Therefore, procurement of the materials described above is not an option, but a requirement of accreditation for all VA laboratories. Scope The overall purpose of this requirement is to obtain a vendor to provide CLIA �88 approved proficiency testing and linearity materials, which are not already provided through P&LMS VACO funding. This will ensure that all laboratories and ancillary testing sites that perform patient testing, within the Veterans Administration North Texas Health Care System (VANTHCS), follow VHA Handbook 1106, 42 CFR 493 Subpart H & K requirements, and CAP accreditation standards. For this award, the proficiency testing program must be approved for the following CLIA specialties: Anatomic Pathology, Microbiology, Diagnostic and General Immunology, and Routine and Special Chemistry. Location The proficiency and linearity materials will be utilized for compliance testing in the P&LMS Department of the VANTHCS System, including: the Dallas VAMC, Sam Rayburn Memorial Medical Center (Bonham, TX), and Fort Worth VA Outpatient Clinic. Period of Performance The Contract period of performance shall be January 01, 2027, through December 31, 2027. Type of Contract NCO 17 and VANTHCS intends to award a contract to the vendor who can supply the following for the Beckman DxC 700 AU (Bonham), Beckman DxI 9000 Access (Bonham, Fort Worth and Dallas), Beckman Coulter AU 5822 (Dallas), TOSOH A1c G8 (Bonham, Fort Worth, and Dallas) and Abbott Alinity I (Dallas) during the contract period: General Chemistry/Lipid/Enzyme Linearity material for plasma/serum Albumin, Calcium, Chloride, CO2, Creatinine, Glucose, Iron, Magnesium, Osmolality, Phosphorous, Potassium, Total Protein, Sodium, BUN, Uric Acid, Alkaline Phos, ALT (GPT), Amylase, AST (SGOT), CK, CKMB, GGT, LDH, Lipase, Total and Direct Bilirubin, Cholesterol, HDL, and Triglycerides linearity/calibration verification (4 surveys per year). Therapeutic Drug Linearity material for plasma/serum Lithium (2 surveys per year). Urine Chemistry Linearity material for Calcium, Chloride, Creatinine, Glucose, Osmolality, Phosphorus, Potassium, Total Protein, Sodium, Urea Nitrogen, Uric Acid (2 surveys per year). Linearity material to monitor test: Ammonia (4 surveys per year). Linearity material to monitor test: Serum Ethanol (3 surveys per year). Linearity material for molecular diagnostics tests: HBV, HCV, and HIV Viral Loads (1 survey for each Viral Load per year). Linearity material to monitor test: Hemoglobin A1C (3 surveys per year). Vendor will also provide the following proficiency testing (PT) surveys, calibration/linearity, and competency assessment materials for the following: Instrumentation calibration/linearity verification materials including Gravimetric pipette calibration, Microtiter plate linearity, Refractometer calibration, Spectrophotometer stray light check, fluorescent intensity check, and pH meter check. Interlaboratory Comparison Non-GYN Cytology PT surveys for nine (9) pathologists and one (1) cytotechnologist. (2 surveys per year). Laboratory Preparedness check for Microbiology section to ensure the laboratory is ready for handling of dangerous organisms (1 survey per year). Eluate competency assessment for Transfusion Medicine section (2 surveys per year). Miscellaneous survey replacement samples are required as needed in the case of instrument malfunction during processing or technical exception. Tasks Task 1: Proficiency Testing and Linearity program The contractor must be on the CMS list of CLIA-approved proficiency testing providers for Chemistry, Diagnostic Immunology, Immunoglobulins, Microbiology/Bacteriology, Urinalysis, and Cytology. The contractor�s program must be a CLIA approved proficiency testing program that supplies both proficiency testing and linearity materials. The proficiency testing/linearity program must: Provide at a minimum the following specimens or materials within the VANTHCS System: General Chemistry Linearity materials for both plasma/serum that include all listed analytes to be shipped to Dallas VAMC (2), FWOPC (1), and Bonham (1) approximately every six months. Therapeutic Drug Linearity materials for Lithium (2 shipments approximately every six months to Dallas VAMC). Urine Chemistry Linearity materials (2 shipments approximately every six months to Dallas VAMC). Ammonia Linearity materials shipped to Dallas VAMC (2), Bonham (1), and FWOP (1) approximately every six months. Serum Ethanol Linearity materials shipped to Dallas VAMC (2) and Bonham (1) approximately every six months. HBV, HCV and HIV Viral Load Linearity materials shipped to Dallas VAMC (1 of each Viral Load noted) approximately every six months. Hemoglobin A1C Linearity material to monitor A1C test shipped to Dallas VAMC (2) FWOPC (1), and Bonham (1) approximately every six months. Instrumentation Linearity materials shipped to Dallas VAMC approximately every six months. Interlaboratory Comparison Non-GYN Cytology PT surveys for nine (9) pathologists and one (1) cytotechnologist shipped to Dallas VAMC approximately every six months. Laboratory Preparedness Survey materials shipped to Dallas VAMC (1) approximately every six months. Eluate competency assessment materials shipped to Dallas VAMC (2) approximately every six months. Include a mechanism for the contractor to notify the following in the VANTHCS System: VANTHCS Contract Officer Representative (COR), VANTHCS Laboratory Manager, VANTHCS Quality Medical Technologist (QMT), and each individual laboratory point of contact (POC) of any PT/linearity updates. Include a contractor established event calendar and/or shipping table that identifies the date each PT/linearity is scheduled to be shipped to the laboratory. The contractor is to ensure that PT/linearity materials are shipped at the proper temperature to ensure viability of specimens when they arrive at the testing laboratory. Have a mechanism that allows each individual laboratory to transmit PT/linearity results electronically via a secure website or by facsimile. Include formal evaluation of results for each test. Formal evaluation reports must include: A mechanism for each laboratory to compare its PT performance or results against peer laboratories using the same method (when applicable). A summary of the individual laboratory�s historic performance over the past three PT events. Overall performance indicates whether current performance is satisfactory, at risk pending future performance, or unsatisfactory. A summary of peer participant results (when applicable). The reason any proficiency te
Who won similar work
11 award notices on SAM.gov in the last 24 months. Matched by: Same office (257-NETWORK CONTRACT OFFICE 17 (36C257)), same product/service code (PSC) 6640 and NAICS 334516.
Single-winner award sizes (9): middle half $238K to $1.1M, median $295K; range $40K to $1.6M.
| Winner | Awards | Value | Last |
|---|---|---|---|
| ABBOTT LABORATORIES INC. · $ABT · $40.1B | 2 | $1.9M | Jun 24, 2025 |
| BECKMAN COULTER, INC | 2 | $1.3M | Jan 28, 2026 |
| BECTON, DICKINSON AND COMPANY · $BDX · $19.4B | 1 | $1.3M | Aug 2, 2025 |
| CEPHEID SUNNYVALE 94089 | 1 | $333K | May 15, 2026 |
| AGILENT TECHNOLOGIES, INC. · $A · $6.8B | 1 | $295K | Jul 14, 2026 |
| GOVERNMENT SCIENTIFIC SOURCE INC | 1 | $271K | Feb 18, 2026 |
| POLYMEDCO CANCER DIAGNOSTIC PRODUCTS LLC | 1 | $40K | Jan 28, 2025 |
| ORTHO-CLINICAL DIAGNOSTICS, INC · $QDEL · $3.0B | 1 | – + 1 shared | May 20, 2025 |
| WERFEN USA LLC | 1 | – + 1 shared | May 15, 2025 |
Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in. Revenue next to a ticker is the company's last annual revenue from its 10-K.
- $ABT reported $40.1B revenue in FY2025. The median single-winner award in these 9 past awards, $295K, is under 0.1% of that. 10-K
- $BDX reported $19.4B revenue in FY2025. The median single-winner award in these 9 past awards, $295K, is under 0.1% of that. 10-K
- $A reported $6.8B revenue in FY2025. The median single-winner award in these 9 past awards, $295K, is under 0.1% of that. 10-K
- $QDEL reported $3.0B revenue in FY2025. The median single-winner award in these 9 past awards, $295K, is under 0.1% of that. 10-K
One award's total value against one year of revenue; many awards are paid over several years.
- Jul 14, 2026AGILENT TECHNOLOGIES, INC.$295K6640--NEW - Seahorse XF Pro Analyzer - Laboratory Instrumentation
- May 15, 2026CEPHEID SUNNYVALE 94089$333K6640--Molecular Diagnostic System
- Feb 18, 2026GOVERNMENT SCIENTIFIC SOURCE INC$271K6640--CTX Immunoassay Random Access Multiplex Analyzer
- Jan 28, 2026BECKMAN COULTER, INC$1.1M6640--NEW - Automated Hematology CPRR and Instrumentation
- Sep 16, 2025BECKMAN COULTER, INC$171K6640--STVHCS Microscan MALDI Cost Per Test
- Aug 2, 2025BECTON, DICKINSON AND COMPANY$1.3M6640--CTX Microbiology Automation System
- Jun 24, 2025ABBOTT LABORATORIES INC.$1.6M6640--Immunoassay CPRR (HIV, HEP, Tacrolimus)
- May 20, 2025ORTHO-CLINICAL DIAGNOSTICS, INC$334K (shared ceiling)6640--STVHCS - Automated Blood Bank Analyzer - Cost Per Test
- May 15, 2025WERFEN USA LLC$334K (shared ceiling)6640--STVHCS - Automated Blood Bank Analyzer - Cost Per Test
- Feb 24, 2025ABBOTT LABORATORIES INC.$238K6640--NEW - VCB Automation Line Bridge 3mo+3mo
Competitive landscape
For the 8 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.
- 1 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (5 filings)
- 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
- $72K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Veterans' Affairs, Senate Committee on Appropriations, Senate Committee on Veterans' Affairs
- 0 foreign-agent (FARA) registrations
Policy around it
Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.
- 5 bills named on the past winners' lobbying filings
- 25 rules from the department in the last 12 months
- 0 executive orders naming the agency in the last 12 months
Market
For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards. A sale marked 10b5-1 was made under a trading plan set up in advance.
- 4 of the past winners are listed companies
- 0 insider buys and 7 insider sells at them in the last 90 days
Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.
Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.